| Bioactivity | KRAS G12D inhibitor 24 (compound 103) is a potent inhibitor of KRAS G12D, with the IC50 of 0.004 μM. KRAS G12D inhibitor 24 has oral bioactivity[1]. |
| CAS | 3033701-29-7 |
| Formula | C34H33F3N6O2 |
| Molar Mass | 614.66 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Tyligand Bioscience (Shanghai) Limited. Quinazoline compounds as KRAS inhibitors and their preparation, pharmaceutical compositions and use in the treatment of cancer. World Intellectual Property Organization, WO2024067714 A1 2024-04-04 |
KRAS G12D inhibitor 24
CAS: 3033701-29-7 F: C34H33F3N6O2 W: 614.66
KRAS G12D inhibitor 24 (compound 103) is a potent inhibitor of KRAS G12D, with the IC50 of 0.004 μM. KRAS G12D inhibito
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.